Literature DB >> 2514188

Interaction between cisplatin and mesna in mice.

R T Dorr1, K Lagel.   

Abstract

The uroprotectant thiol mesna was found to protect adult CD-1 mice from high-dose cisplatin lethality. Mesna doses of 50 mg/kg were given with cisplatin, or 5 min after cisplatin (25 or 30 mg/kg) and acute survival was increased in non-tumor-bearing mice. In contrast, mesna mixed directly with cisplatin significantly reduced cisplatin antitumor effects in DBA/2J mice given 10(6) P-388 leukemia i.p. Mesna administered i.p. 5 min after cisplatin (6, 8 or 10 mg/kg) did not reduce cisplatins' antitumor efficacy in this same tumor model. Mesna appears to inactivate cisplatin directly in vitro but possibly not in vivo if separate injections are used.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2514188     DOI: 10.1007/bf00391367

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  8 in total

Review 1.  Mesna--a short review.

Authors:  I C Shaw; M I Graham
Journal:  Cancer Treat Rev       Date:  1987-06       Impact factor: 12.111

Review 2.  Platinum nephrotoxicity.

Authors:  N E Madias; J T Harrington
Journal:  Am J Med       Date:  1978-08       Impact factor: 4.965

3.  Evaluation of survival data and two new rank order statistics arising in its consideration.

Authors:  N Mantel
Journal:  Cancer Chemother Rep       Date:  1966-03

4.  Controlled clinical studies with an antidote against the urotoxicity of oxazaphosphorines: preliminary results.

Authors:  W Scheef; H O Klein; N Brock; H Burkert; U Günther; H Hoefer-Janker; D Mitrenga; J Schnitker; R Voigtmann
Journal:  Cancer Treat Rep       Date:  1979-03

Review 5.  Cisplatin (cis-diamminedichloroplatinum II).

Authors:  A W Prestayko; J C D'Aoust; B F Issell; S T Crooke
Journal:  Cancer Treat Rev       Date:  1979-03       Impact factor: 12.111

6.  Effect of sodium thiosulfate on cis-dichlorodiammineplatinum(II) toxicity and antitumor activity in L1210 leukemia.

Authors:  S B Howell; R Taetle
Journal:  Cancer Treat Rep       Date:  1980 Apr-May

7.  Studies on the urotoxicity of oxazaphosphorine cytostatics and its prevention--III. Profile of action of sodium 2-mercaptoethane sulfonate (mesna).

Authors:  N Brock; J Pohl; J Stekar; W Scheef
Journal:  Eur J Cancer Clin Oncol       Date:  1982-12

8.  Intraperitoneal cisplatin with systemic thiosulfate protection.

Authors:  S B Howell; C L Pfeifle; W E Wung; R A Olshen; W E Lucas; J L Yon; M Green
Journal:  Ann Intern Med       Date:  1982-12       Impact factor: 25.391

  8 in total
  1 in total

1.  Influence of mesna on the pharmacokinetics of cisplatin and carboplatin in pediatric cancer patients.

Authors:  Shahbal B Kangarloo; Suman B Gangopadhyay; Rachel M Syme; Johannes E A Wolff; Stefan Glück
Journal:  Med Oncol       Date:  2004       Impact factor: 3.064

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.